Your Messages Inbox
Your Article Summary
See Latest ArticlesWatson Pharmaceuticals Receives FDA Approval for Generic Toprol XL 25 MG and 50 MG
Watson Pharmaceuticals, 08/05/09
Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced that its subsidiary, Watson Laboratories, Inc., has received approval from the United States Food and Drug Administration on its Abbreviated New Drug Applications for metoprolol succinate extended–release tablets USP in the 25 mg and 50 mg strengths. Metoprolol succinate extended–release tablets are the generic equivalent to AstraZeneca's Toprol XL(R) tablets. Metoprolol succinate extended–release is a beta–blocker used to treat angina, heart failure and high blood pressure.
Today in Drug/Product Approvals...keeping you current
Receive free subspecialty "5-minute updates" via email
Novartis receives approval in the European Union for Onbrez Breezhaler, a new once-daily bronchodilator for patients with COPD
Novartis, 12/04/09
Teva Announces The Submission Of A Biologics License Application (BLA) For XM02 For The Treatment Of Chemotherapy-Induced Neutropenia
Teva Pharmaceutical Industries, 12/02/09
Bayer's Betaferon approved in China for Treatment of Multiple Sclerosis
BayNews International, 12/02/09
Article Search
Sponsor